Tyrx names new vice president of business development

Most recently, Mr Landau has served as vice president of business development and marketing planning and member of the senior management team at Tengion, a regenerative medicine company.

Prior to Tengion, Mr Landau was with Cordis, Johnson & Johnson’s interventional cardiology franchise, where he served as executive director of new business development.

William Edelman, president and CEO for Tyrx, said: “George brings to Tyrx a business development capability uniquely suited to our growing presence in implantable combination drug/device products. George’s clear track record of building successful, value creating transactions will accelerate our trajectory as an innovative leader in the medical device industry.”